CN107854484A - A kind of peritoneal dialysis solution - Google Patents
A kind of peritoneal dialysis solution Download PDFInfo
- Publication number
- CN107854484A CN107854484A CN201711056132.6A CN201711056132A CN107854484A CN 107854484 A CN107854484 A CN 107854484A CN 201711056132 A CN201711056132 A CN 201711056132A CN 107854484 A CN107854484 A CN 107854484A
- Authority
- CN
- China
- Prior art keywords
- peritoneal dialysis
- dialysis solution
- chloride
- glucose
- fucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- External Artificial Organs (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of peritoneal dialysis solution, belong to medical field of dialysis, including the 15%W/V of sodium chloride 10, calcium chloride be 0.2 5%W/V, potassium chloride is 2 5%W/V, sodium acid carbonate is 2 5%W/V, magnesium chloride 2 5%W/V, the 10W/V of fucose 2 and the glucose less than 5%W/V.
Description
Technical field
The present invention relates to field of dialysis, a kind of specifically peritoneal dialysis solution.
Background technology
Dialysis(dialysis)It is that water is diffused into through semi-permeable membrane by small molecule(Or buffer solution)Principle, by small molecule
A kind of separating and purifying technology separated with large biological molecule.Dialysis therapy is to make the composition in body fluid(Solute or moisture)Pass through half
The treatment method that permeable membrane excretes, it generally can be divided into two kinds of haemodialysis and peritoneal dialysis.
Peritoneal dialysis(Peritoneal dialysis, PD)Be by the use of human body itself peritonaeum as dialysis membrane one kind
Dialysis.Solute and moisture are carried out by pouring into the plasma fraction in the dialyzate in abdominal cavity and the capillary of peritonaeum opposite side
Exchange, remove the metabolite of internal retention and excessive moisture, while pass through dialyzate and supplement material necessary to body.
By constantly updating peritoneal dialysis liquid, reach kidney replacement or the purpose of supportive treatment.
Existing peritoneal dialysis is mainly used as osmotic pressure agent by glucose, among the process of dialysis, part glucose meeting
By body absorption so that blood glucose rise, among metabolic disorder, and sterilization process harmful substance caused by glucose to human body all
There is very big influence, influence dialysis-effect, while dewatering is poor.
The content of the invention
It is an object of the invention to:For above-mentioned problem, there is provided a kind of peritoneal dialysis solution, it is characterised in that bag
It is 2-5 %W/V to include sodium chloride 10-15% W/V, calcium chloride 0.2-5%W/V, potassium chloride 2-5%W/V, sodium acid carbonate, chlorination
Magnesium 2-5 %W/V, fucose 2-10 %W/V and the glucose less than 5%W/V.
Preferably, described fucose is 5-8% W/V, the concentration of glucose is less than 3%W/V.
Preferably, the concentration of each material is sodium chloride is 10% W/V, calcium chloride 0.2%W/V, potassium chloride 2%W/V,
Glucose is 2% W/V, and sodium acid carbonate is 3 %W/V.
Preferably, the concentration of each material is sodium chloride is 12% W/V, calcium chloride 2%W/V, potassium chloride 3%W/V, Portugal
Grape sugar is 2% W/V, and fucose is that 8 %W/V sodium acid carbonates are 3 %W/V.
Preferably, the pH value in dialyzate is 5-8.
Preferably, pH value is 6-7.5.
The invention also discloses a kind of preparation method of dialyzate, comprise the following steps:
Step 1: other materials in addition to fucose and glucose and water are mixed, homogeneous solution is formed;
Step 2: sterilization treatment is carried out at high temperature;
Step 3: adding fucose and glucose, homogeneous solution is formed;
Step 4: use filtering with microporous membrane.
A kind of preparation method of peritoneal dialysis solution according to claim 6, it is characterised in that described miillpore filter
Filtering particle diameter be 0.2-0.4 μm.
Embodiment
In order to make the purpose , technical scheme and advantage of the present invention be clearer, with reference to embodiments, to the present invention
It is further elaborated.It should be appreciated that the specific embodiments described herein are merely illustrative of the present invention, it is not used to
Limit the present invention.
Specific embodiment 1:A kind of peritoneal dialysis solution, including sodium chloride 10-15% W/V, calcium chloride 0.2-5%W/V, chlorine
Change potassium be 2-5%W/V, sodium acid carbonate be 2-5 %W/V, magnesium chloride 2-5 %W/V, fucose 2-10 %W/V and less than 5%W/V
Glucose.Described fucose is 5-8% W/V, and the concentration of glucose is less than 3%W/V.
Specific embodiment 2:The concentration of each material be sodium chloride be 10% W/V, calcium chloride 0.2%W/V, potassium chloride 2%
W/V, glucose are 2% W/V, and fucose is 8 %W/V, and sodium acid carbonate is 3 %W/V, and pH value is adjusted to 7.
The concentration of 3 each material of specific embodiment be sodium chloride be 12% W/V, calcium chloride 2%W/V, potassium chloride 3%W/V, grape
Sugar is 2% W/V, and fucose is that 8 %W/V sodium acid carbonates are 3 %W/V, and PH is adjusted to 6
Specific embodiment 4:Step 1: other materials in addition to fucose and glucose and water are mixed, homogeneous solution is formed;
Step 2: sterilization treatment is carried out at high temperature;
Step 3: adding fucose and glucose, homogeneous solution is formed;
Step 4: use filtering with microporous membrane.The filtering particle diameter of described miillpore filter is 0.2-0.4 μm.
Specific embodiment 5;Specific embodiment 5 is a comparative example relative to 2:The concentration of each material is sodium chloride
It is 10% W/V for 10% W/V, calcium chloride 0.2%W/V, potassium chloride 2%W/V, glucose, sodium acid carbonate is 3 %W/V, pH value
It is adjusted to 7.
Specific embodiment 6:It is a comparative example of embodiment 3:The concentration of each material is that sodium chloride is 12% W/V, chlorination
Calcium is 2%W/V, potassium chloride 3%W/V, glucose are 10% W/V, and sodium acid carbonate is 3 %W/V, and PH is adjusted to 6.
In embodiment, tested with the white mouse of anesthesia, by 10ml, embodiment 2-3,5-6, injection white mouse is intraperitoneal, and 10
After hour, intraperitoneal liquid is reclaimed(Subtract the amount of liquid for anaesthetizing withdrawal liquid immediately), measure the liquid of embodiment 5 and embodiment 6
The scale of construction is respectively 42 and 56, and the amount of liquid that embodiment 2 and 3 reclaims is respectively 64 and 78.
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all essences in the present invention
All any modification, equivalent and improvement made within refreshing and principle etc., should be included in the scope of the protection.
Claims (8)
1. a kind of peritoneal dialysis solution, it is characterised in that including sodium chloride 10-15% W/V, calcium chloride 0.2-5%W/V, potassium chloride
It is 2-5 %W/V, magnesium chloride 2-5 %W/V, fucose 2-10 %W/V and the Portugal less than 5%W/V for 2-5%W/V, sodium acid carbonate
Grape sugar.
2. peritoneal dialysis solution according to claim 1, it is characterised in that described fucose is 5-8% W/V, glucose
Concentration be less than 3%W/V.
3. peritoneal dialysis solution according to claim 2, it is characterised in that the concentration of each material is that sodium chloride is 10% W/
V, calcium chloride be 0.2%W/V, potassium chloride 2%W/V, glucose be 2% W/V, sodium acid carbonate is 3 %W/V.
4. peritoneal dialysis solution according to claim 1, it is characterised in that the concentration of each material is
Sodium chloride is 12% W/V, calcium chloride 2%W/V, potassium chloride 3%W/V, glucose are 2% W/V, and fucose is 8 %W/V
Sodium acid carbonate is 3 %W/V.
5. peritoneal dialysis solution according to claim 4, it is characterised in that the pH value in dialyzate is 5-8.
6. peritoneal dialysis solution according to claim 5, it is characterised in that pH value 6-7.5.
7. the preparation method of the peritoneal dialysis solution according to claim any one of 1-5, it is characterised in that including following step
Suddenly:
Step 1: other materials in addition to fucose and glucose and water are mixed, homogeneous solution is formed;
Step 2: sterilization treatment is carried out at high temperature;
Step 3: adding fucose and glucose, homogeneous solution is formed;
Step 4: use filtering with microporous membrane.
8. the preparation method of a kind of peritoneal dialysis solution according to claim 6, it is characterised in that described miillpore filter
It is 0.2-0.4 μm to filter particle diameter.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711056132.6A CN107854484A (en) | 2017-10-27 | 2017-10-27 | A kind of peritoneal dialysis solution |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711056132.6A CN107854484A (en) | 2017-10-27 | 2017-10-27 | A kind of peritoneal dialysis solution |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107854484A true CN107854484A (en) | 2018-03-30 |
Family
ID=61696446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711056132.6A Withdrawn CN107854484A (en) | 2017-10-27 | 2017-10-27 | A kind of peritoneal dialysis solution |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107854484A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101890041A (en) * | 2010-02-10 | 2010-11-24 | 上海蓝怡科技有限公司 | Peritoneal dialysis solution and preparation method thereof |
-
2017
- 2017-10-27 CN CN201711056132.6A patent/CN107854484A/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101890041A (en) * | 2010-02-10 | 2010-11-24 | 上海蓝怡科技有限公司 | Peritoneal dialysis solution and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
韩明亮,等: "《食品化学》", 30 September 2005, 延边大学出版社 * |
顾学裘,等: "《药物制剂注解》", 31 May 1983, 人民卫生出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4778681B2 (en) | Bicarbonate-based solutions for dialysis therapy | |
CN105992599B (en) | Cylindrantherae for cleaning dialysis solutions | |
KR101813740B1 (en) | Dialysis precursor composition | |
CA2741572C (en) | Portable peritoneal dialysis system | |
CN105008893B (en) | PH buffer measuring system for hemodialysis system | |
WO2011130528A1 (en) | Anticoagulant-free dialysis systems and methods | |
CN108430529A (en) | system and method for extracorporeal blood treatment | |
WO2014113740A1 (en) | Removal of carbon dioxide via dialysis | |
JP2003534052A (en) | Medical carbohydrate solutions and bisulfite stabilizers in multi-compartment containers and uses thereof | |
CN107854484A (en) | A kind of peritoneal dialysis solution | |
CN107854483A (en) | A kind of preparation method of peritoneal dialysis solution | |
CN107854482A (en) | A kind of high peritoneal dialysis solution of dehydration rate | |
HUT68062A (en) | Method and liquids includiug hydrochloric acid for hemodialysis, and concentrate of two container for hemodialysing equipment | |
CN114869906A (en) | Dialysis concentrate and preparation and quality detection method thereof | |
CN103932981A (en) | Heparin sodium tube-sealing injection | |
CN109078019B (en) | Bicarbonate dialysate packaged by double-chamber bag and preparation method thereof | |
CN107854481A (en) | A kind of collocation method of blood dialysis solution | |
KR101978010B1 (en) | Dialysis precursor composition | |
CN107684558A (en) | A kind of blood dialysis solution | |
CN107890471A (en) | A kind of anticoagulant hemodialysis liquid | |
KR101978011B1 (en) | Dialysis precursor composition | |
CN205145229U (en) | Hemodialyzer | |
Zulkarnaev | A brief history of the study of diffusion and osmosis in the context of dialysis | |
Ota et al. | A new method of urea removal using urease and expanded polytetrafluoroethylene membrane | |
Kobayashi et al. | FP535 EFFECT OF CONTACT WITH A VITAMIN E-COATED DIALYSIS MEMBRANE ON THE GENE EXPRESSION PFOFILE OF MONOCYTES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180330 |
|
WW01 | Invention patent application withdrawn after publication |